[HTML][HTML] Detection of plasma biomarkers using immunomagnetic reduction: a promising method for the early diagnosis of Alzheimer's disease
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and therapy, 2017 - Springer
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen… - Neurology and …, 2017 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and Therapy, 2017 - europepmc.org
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
[引用][C] Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and Therapy, 2017 - cir.nii.ac.jp
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for
the Early Diagnosis of Alzheimer’s Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
the Early Diagnosis of Alzheimer’s Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML][HTML] Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and Therapy, 2017 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.
SY Yang, MJ Chiu, TF Chen… - Neurology & …, 2017 - search.ebscohost.com
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
S Yang, M Chiu, T Chen, H Horng - Neurology and Therapy, 2017 - search.proquest.com
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and Therapy, 2017 - infona.pl
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen… - Neurology and …, 2017 - scholar.lib.ntnu.edu.tw
摘要Alzheimer's disease (AD) is the most common form of dementia. The development of
assay technologies able to diagnose early-stage AD is important. Blood tests to detect …
assay technologies able to diagnose early-stage AD is important. Blood tests to detect …
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease
SY Yang, MJ Chiu, TF Chen, HE Horng - Neurology and Therapy, 2017 - infona.pl
Alzheimer's disease (AD) is the most common form of dementia. The development of assay
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …
technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers …